Looking for leads, investment insights, or competitive intelligence?
News about Novartis
Rani Therapeutics wants to take the needle out of the equation.
Half the world’s population lacks access to essential health services.
Juno's stock is up a staggering 76% since rumors of the Celgene deal emerged last week.
The FDA approved 46 novel drugs in 2017 versus 22 in 2016.